Peter Wark

18.9k total citations · 4 hit papers
247 papers, 10.9k citations indexed

About

Peter Wark is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Peter Wark has authored 247 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Pulmonary and Respiratory Medicine, 118 papers in Physiology and 62 papers in Immunology. Recurrent topics in Peter Wark's work include Asthma and respiratory diseases (115 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (59 papers) and Respiratory and Cough-Related Research (43 papers). Peter Wark is often cited by papers focused on Asthma and respiratory diseases (115 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (59 papers) and Respiratory and Cough-Related Research (43 papers). Peter Wark collaborates with scholars based in Australia, United Kingdom and Canada. Peter Wark's co-authors include Peter G. Gibson, Sebastian L. Johnston, Philip M. Hansbro, Vanessa M. McDonald, Jodie L. Simpson, Lisa G. Wood, Donna E. Davies, Stephen T. Holgate, Alan Hsu and Vasile Laza‐Stanca and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Peter Wark

240 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus

2005 916 citations Peter Wark et al. profile →
Role of deficient type III interferon-λ production in asthma exacerbations

2006 777 citations Peter Wark, Nathan W. Bartlett et al. profile →
Role for NLRP3 Inflammasome–mediated, IL-1β–Dependent Responses in Severe, Steroid-Resistant Asthma

2017 315 citations Richard Kim, Katherine J. Baines et al. profile →
Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease

2020 264 citations Kate L Bowerman, Saima Firdous Rehman et al. Nature Communications profile →

Peers

Countries citing papers authored by Peter Wark

Since Specialization

Citations

This map shows the geographic impact of Peter Wark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wark more than expected).

Fields of papers citing papers by Peter Wark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wark. The network helps show where Peter Wark may publish in the future.

Co-authorship network of co-authors of Peter Wark

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wark. A scholar is included among the top collaborators of Peter Wark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wark. Peter Wark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adverse Events and Drug Interactions Associated with Elexacaftor/Tezacaftor/Ivacaftor Treatment: A Descriptive Study Across Australian, Canadian, and American Adverse Event Databases 2025 ·Life ·(unknown), (unknown), (unknown), Vincent Chan, (unknown), Kingsley Coulthard, Peter Wark, Vijayaprakash Suppiah	0
2	Biologic therapies for severe asthma with persistent type 2 inflammation 2024 ·Australian Prescriber ·(unknown), Peter Wark	2
3	The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment 2024 ·Proteomes ·(unknown), Matthew B. O’Rourke, Matthew P. Padula, Fernando Souza-Fonseca-Guimarães, Gaetano Caramori, Peter Wark, (unknown), Philip M. Hansbro	2
4	The Complex Association between COPD and COVID-19 2023 ·Journal of Clinical Medicine ·Nikhil T Awatade, Peter Wark, Andrew S. L. Chan, (unknown), (unknown), Kazuto Matsunaga, Chin Kook Rhee, Philip M. Hansbro, Sukhwinder Singh Sohal, (unknown)	24
5	Ventilation Heterogeneity Is a Treatable Trait in Severe Asthma 2023 ·The Journal of Allergy and Clinical Immunology In Practice ·Peter G. Gibson, (unknown), (unknown), Natalie Rutherford, (unknown), (unknown), Christopher Grainge, Peter Wark, Vanessa M. McDonald	4
6	Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts 2022 ·Respirology ·(unknown), Stelios Pavlidis, Nazanin Zounemat Kermani, Katherine J. Baines, Daniel Barker, Peter G. Gibson, Lisa G. Wood, Ian M. Adcock, Kian Fan Chung, Jodie L. Simpson, Peter Wark	7
7	Probiotic Bifidobacterium longum subsp. longum Protects against Cigarette Smoke-Induced Inflammation in Mice 2022 ·International Journal of Molecular Sciences ·Kurtis F. Budden, Shaan L. Gellatly, Annalicia Vaughan, Nadia Amorim, Jay C. Horvat, Nicole G. Hansbro, David Wood, Philip Hugenholtz, Paul G. Dennis, Peter Wark, Philip M. Hansbro	17
8	Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma 2021 ·Allergy Asthma and Immunology Research ·(unknown), Peter G. Gibson, Michael Fricker, Jodie L. Simpson, Peter Wark, Vanessa M. McDonald	13
9	Transcriptomics of biopsies identifies novel genes and pathways linked to neutrophilic inflammation in severe asthma 2021 ·Clinical & Experimental Allergy ·(unknown), Jodie L. Simpson, Daniel Barker, Katherine J. Baines, Peter Wark	16
10	TLR2-mediated innate immune priming boosts lung anti-viral immunity 2020 ·European Respiratory Journal ·Jason Girkin, Su-Ling Loo, Camille Esneau, Steven Maltby, Francesca Mercuri, Brendon Y. Chua, Andrew T. Reid, Punnam Chander Veerati, Christopher Grainge, Peter Wark, Darryl A. Knight, David C. Jackson, Christophe Demaison, Nathan W. Bartlett	26
11	Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease breakdown → 2020 ·Nature Communications ·Kate L Bowerman, Saima Firdous Rehman, Annalicia Vaughan, Nancy Lachner, Kurtis F. Budden, Richard Kim, David Wood, Shaan L. Gellatly, Shakti D. Shukla, Lisa G. Wood, Ian A. Yang, Peter Wark, Philip Hugenholtz, Philip M. Hansbro	264
12	Molecular and Immunological Mechanisms Underlying the Various Pharmacological Properties of the Potent Bioflavonoid, Rutin 2020 ·Endocrine Metabolic & Immune Disorders - Drug Targets ·(unknown), (unknown), Dinesh Kumar Chellappan, Thiagarajan Madheswaran, Jithendra Panneerselvam, Hira Choudhury, Manisha Pandey, Yik Lung Chan, Trudi Collet, Gaurav Gupta, Brian G. Oliver, Peter Wark, Nicole G. Hansbro, Alan Hsu, Philip M. Hansbro, Kamal Dua, Farrukh Zeeshan	26
13	Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand* 2020 ·Respirology ·Jack Dummer, Claudia C. Dobler, Mark Holmes, Daniel C. Chambers, Ian A. Yang, Lianne Parkin, Sheree Smith, Peter Wark, Anouk Dev, Sandra Hodge, Eli Dabscheck, Julian Gooi, (unknown), (unknown), Anne E. Holland	9
14	<p>A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD</p> 2020 ·International Journal of COPD ·Katherine J. Baines, Netsanet A. Negewo, Peter G. Gibson, Juan Fu, Jodie L. Simpson, Peter Wark, Michael Fricker, Vanessa M. McDonald	10
15	Curcumin-Loaded Niosomes Downregulate mRNA Expression of Pro-Inflammatory Markers Involved in Asthma: An In Vitro Study 2020 ·Nanomedicine ·(unknown), (unknown), Meenu Mehta, Shakti D. Shukla, Jithendra Panneerselvam, Thiagarajan Madheswaran, Gaurav Gupta, Poonam Negi, Pradeep Kumar, Viness Pillay, Alan Hsu, Nicole G. Hansbro, Peter Wark, Mary Bebawy, Philip M. Hansbro, (unknown), Dinesh Kumar Chellappan	14
16	Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report 2019 ·European Respiratory Journal ·Vanessa M. McDonald, James Fingleton, Àlvar Agustí, Sarah A. Hiles, Vanessa Clark, Anne E. Holland, Guy B. Marks, Philip G. Bardin, Richard Beasley, Ian Pavord, Peter Wark, Peter G. Gibson	199
17	<p>Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression</p> 2019 ·International Journal of COPD ·Ravi Lokwani, Peter Wark, Katherine J. Baines, Michael Fricker, Daniel Barker, Jodie L. Simpson	12
18	Hypoxia‐inducible factor and bacterial infections in chronic obstructive pulmonary disease 2019 ·Respirology ·Shakti D. Shukla, E. Haydn Walters, Jodie L. Simpson, Simon Keely, Peter Wark, Ronan O’Toole, Philip M. Hansbro	44
19	Trends in asthma self-management skills and inhaled corticosteroid use during pregnancy and postpartum from 2004 to 2017 2018 ·Journal of Asthma ·Annelies L. Robijn, Megan E. Jensen, Peter G. Gibson, Heather Powell, Warwick Giles, Vicki L. Clifton, Joërg Mattes, Michael Peek, Helen L. Barrett, Sean Seeho, Leonie Callaway, (unknown), John Attia, Peter Wark, Vanessa E. Murphy	32
20	A short-term model of COPD identifies a role for mast cell tryptase 2013 ·European Respiratory Journal ·Philip M. Hansbro, Emma Beckett, Richard Stevens, Andrew Jarnicki, Peter Wark, Paul S. Foster	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact